FinanceAYR Wellness Has No Estimate for Q1 2025 Interim Filings; Trading Remains on HoldThe cannabis company’s delay in filing its financial statements comes as its negotiations with creditors remain ongoing.AYR Wellness Inc.Posted by CBT StaffJune 27, 2025FacebookLinkedInX (Twitter)Pinterest Add us as a preferred source on Google RecommendedShrink Is Eating Into Cannabis Retail Margins - Here’s How to Stop ItAurora Cannabis Reaffirms Recommendation to Shareholders to Reject Curaleaf's Revised Hostile BidTrulieve Repays $65 Million Mortgage, Strengthening Balance SheetCuraleaf Files Update to Offering CircularRelated StoriesAurora Cannabis Denies 2nd ‘False’ News Report of Acquisition of MedLeaf TherapeuticsVireo Growth Provides Corporate Update After Closing All Merger TransactionsAYR Fails to Complete Q1 2025 Interim Financial Filings; Cease-Trade Order Remains in EffectAYR Wellness Issued Cease Trade Order by Ontario Securities Commission